Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Clinical Lab Management › NeoGenomics Downgraded to Equal-Weight by First Analysis

NeoGenomics Downgraded to Equal-Weight by First Analysis

May 02, 2018
|
staff reporter

NEW YORK (360Dx) – First Analysis Securities today downgraded NeoGenomics to Equal-Weight from Overweight based on the company's valuation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Clinical Lab Management

  1. Labs, Vendors Anticipate COVID-19 Vaccines to Boost Serology Testing Demand

    Premium

  2. Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

  3. Mistakes Were Made in Regulation of SARS-CoV-2 Serology Tests, FDA Officials Acknowledge

    Premium

  4. AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

  5. SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.